Sale

Cardiac Pacemaker Market

Global Cardiac Pacemaker Market Share, Analysis, Forecast: By Product Type: MRI Compatible Pacemaker, Conventional Pacemaker, Implantable Pacemakers, External Pacemakers; By Technology: Single Chamber Pacemaker, Dual Chamber Pacemaker, Others; By Applications; By End User; Regional Analysis; Supplier Landscape; 2024-2032

Global Cardiac Pacemaker Market Outlook

The global cardiac pacemaker market size attained a value of about USD 4.91 billion in 2023. The market is further expected to grow at a CAGR of 3.1% to attain a value of USD 6.48 billion by 2032. The growth of the market can be attributed to the increasing prevalence of heart rhythm disorders, such as bradycardia and heart block.

 

Global Cardiac Pacemaker Market

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Growing Demand in Ambulatory Surgical Centres to Augment the Cardiac Pacemaker Industry Growth

Based on end use, ambulatory surgical centres account for a significant share in the cardiac pacemaker industry. This can be attributed to its advanced consumer penetration and ease of care, especially in rural areas. In this case, ambulatory surgical centres have also proved to be a competent option. In addition, some of the high-impact market drivers for ambulatory surgical centres are projected to be the growing demand for reducing surgical and post-surgical spending and increasing prevalence of cardiovascular diseases.

 

The Asia-Pacific Region to Provide Enhanced Growth Opportunities to the Cardiac Pacemaker Industry

Region-wise, the Asia Pacific is expected to witness a robust growth over the forecast period owing to the increasing cases of cardiovascular disorders in the region. The growth is driven by the market expansion by major players and the presence of significant untapped opportunities. In addition, investment in the healthcare sector has gained momentum, especially in Japan, India, and China. These countries are increasingly focused on building comprehensive heart diagnostic and recovery healthcare facilities. These variables are anticipated to contribute to the market growth in the coming years.

 

Cardiac Pacemaker: Market Segmentation

A pacemaker is a tiny instrument in your chest that is mounted under the skin to help stabilize your heartbeat. It is used if you have an erratic heartbeat (arrhythmia), especially a sluggish one, to make the heartbeat more consistent. It takes a surgical operation to insert a pacemaker in your chest. After a heart attack, surgery, or drug overdose, they may be inserted temporarily to treat a sluggish pulse. Or, they may be permanently inserted to correct a sluggish or erratic pulse or to help treat cardiac disease in certain individuals.

 

Global Cardiac Pacemaker Market

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

By type, the market is divided into:

  • Implantable 
  • External

Based on technology, the market is categorised into:

  • Biventricular
  • Single Chambered  
  • Dual Chambered
  • Others

Based on application, the market is divided into:

  • Arrhythmias
  • Congestive Heart Failure
  • Others

On the basis of end use, the market is segmented into:

  • Hospitals and Clinics
  • Ambulatory Surgery Centres
  • Others

The regional markets for the product include North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.

 

Global Cardiac Pacemaker Market

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Growing Prevalence of Cardiovascular Diseases to Bolster the Growth of the Cardiac Pacemaker Industry

With the rise in people suffering from cardiovascular diseases, the cardiac pacemaker industry is at an all-time high. Citizens all over the world have adopted a sedentary lifestyle, which is leading to obesity, diabetes, and other lifestyle disorders. These lifestyle disorders turn into serious cardiovascular diseases such as high blood pressure, heart attack, and arrhythmia. The rise in poor lifestyle, combined with the technological advancements in the sector is likely to increase the demand for cardiac pacemaker. This is aiding the growth of the overall  market. Further, the reimbursement policies offered by the government has impacted the industry in a positive way. However, lack of understanding of cardiovascular diseases among the population in developed countries and the high medical costs may hamper the market growth.

Over the forecast period, rise in demand for advanced diagnostic facilities and the rapid technological advancements are expected to favour the industry growth. The worldwide increase in the sedentary population is expected to be a major trend in the coming years.

 

Key Industry Players in the Global Cardiac Pacemaker Market

The report gives a detailed analysis of the following key players in the global cardiac pacemaker market, covering their competitive landscape, capacity, and latest developments like mergers, acquisitions, and investments, expansions of capacity, and plant turnarounds:

  • Zoll Medical Corporation
  • MicroPort Scientific Corporation
  • OSCOR Inc.
  • Osypka Medical GmbH
  • Medtronic
  • Abbott
  • Boston Scientific Corporation
  • BIOTRONIK
  • LivaNova
  • Pacetronix
  • MEDICO
  • Osypka Medical
  • Lepu Medical Co ltd.

The comprehensive EMR report provides an in-depth assessment of the market based on the Porter's five forces model along with giving a SWOT analysis.

 

Key Highlights of the Report

REPORT FEATURES DETAILS
Base Year 2023
Historical Period 2017-2023
Forecast Period 2024-2032
Scope of the Report

Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:

  • Product Type
  • Technology
  • Applications
  • End User
  • Region
Breakup by Product Type
  • MRI Compatible Pacemaker
  • Conventional Pacemaker
  • Implantable Pacemakers
  • External Pacemakers
Breakup by Technology
  • Single Chamber Pacemaker
  • Dual Chamber Pacemaker
  • Biventricular/CRT Pacemaker
Breakup by Applications
  • Arrhythmia
  • Atrial Fibrillation
  • Bradycardia
  • Tachycardia
  • Others
Breakup by End User
  • Cardiac Centres
  • Ambulatory surgical Centres
  • Hospitals
  • Clinics
  • Others
Breakup by Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa
Market Dynamics
  • Market Drivers and Constraints
  • SWOT Analysis
  • Porter’s Five Forces Model 
  • Key Demand Indicators
  • Key Price Indicators
  • Industry Events, Initiatives, and Trends 
  • Value Chain Analysis
Supplier Landscape
  • Market Structure
  • Company Profiles
    • Financial Analysis
    • Product Portfolio
    • Demographic Reach and Achievements
    • Mergers and Acquisitions
    • Certifications
Companies Covered
  • Zoll Medical Corporation
  • MicroPort Scientific Corporation
  • OSCOR Inc.
  • Osypka Medical GmbH
  • Medtronic
  • Abbott
  • Boston Scientific Corporation
  • BIOTRONIK
  • LivaNova
  • Pacetronix
  • MEDICO
  • Osypka Medical
  • Lepu Medical Co ltd.

 

*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.

1    Preface
    1.1    Objectives of the Study
    1.2    Key Assumptions 
    1.3    Report Coverage – Key Segmentation and Scope  
    1.4    Research Methodology
2    Executive Summary
3    Global Cardiac Pacemaker Market Overview

    3.1    Global Cardiac Pacemaker Market Historical Value (2017-2023) 
    3.2    Global Cardiac Pacemaker Market Forecast Value (2024-2032)
4    Global Cardiac Pacemaker Market Landscape
    4.1    Global Cardiac Pacemaker Developers Landscape
        4.1.1    Analysis by Year of Establishment
        4.1.2    Analysis by Company Size
        4.1.3    Analysis by Region
    4.2    Global Cardiac Pacemaker Product Landscape
        4.2.1    Analysis by Product Type
        4.2.2    Analysis by Technology
        4.2.3    Analysis by Applications
        4.2.4    Analysis by End User
5    Global Cardiac Pacemaker Market Dynamics
    5.1    Market Drivers and Constraints
    5.2    SWOT Analysis
    5.3    Porter’s Five Forces Model 
    5.4    Key Demand Indicators
    5.5    Key Price Indicators
    5.6    Industry Events, Initiatives, and Trends 
    5.7    Value Chain Analysis
6    Global Cardiac Pacemaker Market Segmentation
    6.1    Global Cardiac Pacemaker Market by Product Type
        6.1.1    Market Overview
        6.1.2    MRI Compatible Pacemaker
        6.1.3    Conventional Pacemaker
        6.1.4    Implantable Pacemakers
        6.1.5    External Pacemakers
    6.2    Global Cardiac Pacemaker Market by Technology
        6.2.1    Market Overview
        6.2.2    Single Chamber Pacemaker
        6.2.3    Dual Chamber Pacemaker
        6.2.4    Biventricular/CRT Pacemaker
    6.3    Global Cardiac Pacemaker Market by Applications
        6.3.1    Market Overview
        6.3.2    Arrhythmia
        6.3.3    Atrial Fibrillation
        6.3.4    Bradycardia
        6.3.5    Tachycardia
        6.3.6    Others
    6.4    Global Cardiac Pacemaker Market by End User
        6.4.1    Market Overview
        6.4.2    Cardiac Centres
        6.4.3    Ambulatory surgical Centres
        6.4.4    Hospitals
        6.4.5    Clinics
        6.4.6    Others
    6.5    Global Cardiac Pacemaker Market by Region
        6.5.1    Market Overview
        6.5.2    North America 
        6.5.3    Europe
        6.5.4    Asia Pacific
        6.5.5    Latin America
        6.5.6    Middle East and Africa
7    North America Cardiac Pacemaker Market
    7.1    Market Share by Country
    7.2    United States of America
    7.3    Canada
8    Europe Cardiac Pacemaker Market
    8.1    Market Share by Country
    8.2    United Kingdom
    8.3    Germany
    8.4    France
    8.5    Italy
    8.6    Others
9    Asia Pacific Cardiac Pacemaker Market
    9.1    Market Share by Country
    9.2    China
    9.3    Japan
    9.4    India
    9.5    ASEAN
    9.6    Australia
    9.7    Others
10    Latin America Cardiac Pacemaker Market
    10.1    Market Share by Country
    10.2    Brazil
    10.3    Argentina
    10.4    Mexico
    10.5    Others
11    Middle East and Africa Cardiac Pacemaker Market
    11.1    Market Share by Country
    11.2    Saudi Arabia
    11.3    United Arab Emirates
    11.4    Nigeria
    11.5    South Africa
    11.6    Others
12    Patent Analysis
    12.1    Analysis by Type of Patent
    12.2    Analysis by Publication year
    12.3    Analysis by Issuing Authority
    12.4    Analysis by Patent Age
    12.5    Analysis by CPC Analysis
    12.6    Analysis by Patent Valuation 
    12.7    Analysis by Key Players
13    Grants Analysis
    13.1    Analysis by year
    13.2    Analysis by Amount Awarded
    13.3    Analysis by Issuing Authority
    13.4    Analysis by Grant Application
    13.5    Analysis by Funding Institute
    13.6    Analysis by NIH Departments
    13.7    Analysis by Recipient Organization 
14    Funding Analysis
    14.1    Analysis by Funding Instances
    14.2    Analysis by Type of Funding
    14.3    Analysis by Funding Amount
    14.4    Analysis by Leading Players
    14.5    Analysis by Leading Investors
    14.6    Analysis by Geography
15    Partnership and Collaborations Analysis
    15.1    Analysis by Partnership Instances
    15.2    Analysis by Type of Partnership
    15.3    Analysis by Leading Players
    15.4    Analysis by Geography
16    Regulatory Framework
    16.1    Regulatory Overview
        16.1.1    US FDA
        16.1.2    EU EMA
        16.1.3    INDIA CDSCO
        16.1.4    JAPAN PMDA
        16.1.5    Others
17    Supplier Landscape
    17.1    Zoll Medical Corporation
        17.1.1    Financial Analysis
        17.1.2    Product Portfolio
        17.1.3    Demographic Reach and Achievements
        17.1.4    Mergers and Acquisitions
        17.1.5    Certifications
    17.2    MicroPort Scientific Corporation
        17.2.1    Financial Analysis
        17.2.2    Product Portfolio
        17.2.3    Demographic Reach and Achievements
        17.2.4    Mergers and Acquisitions
        17.2.5    Certifications
    17.3    OSCOR Inc.
        17.3.1    Financial Analysis
        17.3.2    Product Portfolio
        17.3.3    Demographic Reach and Achievements
        17.3.4    Mergers and Acquisitions
        17.3.5    Certifications
    17.4    Osypka Medical GmbH
        17.4.1    Financial Analysis
        17.4.2    Product Portfolio
        17.4.3    Demographic Reach and Achievements
        17.4.4    Mergers and Acquisitions
        17.4.5    Certifications
    17.5    Medtronic
        17.5.1    Financial Analysis
        17.5.2    Product Portfolio
        17.5.3    Demographic Reach and Achievements
        17.5.4    Mergers and Acquisitions
        17.5.5    Certifications
    17.6    Abbott
        17.6.1    Financial Analysis
        17.6.2    Product Portfolio
        17.6.3    Demographic Reach and Achievements
        17.6.4    Mergers and Acquisitions
        17.6.5    Certifications
    17.7    Boston Scientific Corporation
        17.7.1    Financial Analysis
        17.7.2    Product Portfolio
        17.7.3    Demographic Reach and Achievements
        17.7.4    Mergers and Acquisitions
        17.7.5    Certifications
    17.8    BIOTRONIK
        17.8.1    Financial Analysis
        17.8.2    Product Portfolio
        17.8.3    Demographic Reach and Achievements
        17.8.4    Mergers and Acquisitions
        17.8.5    Certifications
    17.9    LivaNova
        17.9.1    Financial Analysis
        17.9.2    Product Portfolio
        17.9.3    Demographic Reach and Achievements
        17.9.4    Mergers and Acquisitions
        17.9.5    Certifications
    17.10    Pacetronix
        17.10.1    Financial Analysis
        17.10.2    Product Portfolio
        17.10.3    Demographic Reach and Achievements
        17.10.4    Mergers and Acquisitions
        17.10.5    Certifications
    17.11    MEDICO
        17.11.1    Financial Analysis
        17.11.2    Product Portfolio
        17.11.3    Demographic Reach and Achievements
        17.11.4    Mergers and Acquisitions
        17.11.5    Certifications
    17.12    Osypka Medical
        17.12.1    Financial Analysis
        17.12.2    Product Portfolio
        17.12.3    Demographic Reach and Achievements
        17.12.4    Mergers and Acquisitions
        17.12.5    Certifications
    17.13    Lepu Medical Co ltd. 
        17.13.1    Financial Analysis
        17.13.2    Product Portfolio
        17.13.3    Demographic Reach and Achievements
        17.13.4    Mergers and Acquisitions
        17.13.5    Certifications
18    Global Cardiac Pacemaker Market - Distribution Model (Additional Insight)
    18.1    Overview 
    18.2    Potential Distributors 
    18.3    Key Parameters for Distribution Partner Assessment 
19    Key Opinion Leaders (KOL) Insights (Additional Insight)
20    Company Competitiveness Analysis (Additional Insight)

    20.1    Very Small Companies
    20.2    Small Companies
    20.3    Mid-Sized Companies
    20.4    Large Companies
    20.5    Very Large Companies
21    Payment Methods (Additional Insight)
    21.1    Government Funded
    21.2    Private Insurance
    21.3    Out-of-Pocket

 

*Additional insights provided are customisable as per client requirements.

Key Questions Answered in the Report

In 2023, the global cardiac pacemaker market was aided by the growing pacemaker market which attained a volume of nearly 4.91 million units.

The pacemaker market is projected to grow at a CAGR of 3.1% between 2024 and 2032 thereby aiding the growth of the cardiac pacemaker market.

The major drivers of the market include the rise in poor lifestyle, combined with the technological advancements, reimbursement policies offered by the government, rise in demand for advanced diagnostic facilities, increasing focus on building comprehensive heart diagnostic and recovery healthcare facilities, and worldwide increase in the sedentary population.

The rise in people suffering from cardiovascular diseases and the rise in lifestyle disorders like diabetes due to sedentary lifestyle are the key industry trends propelling the market's growth.

The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.

The types of cardiac pacemakers are implantable and external.

Based on technology, the market is categorised into biventricular, single chambered, and dual chambered, among others.

Based on application, the market is classified into arrhythmias and congestive heart failure, among others.

On the basis of end-use, the market is segmented into hospitals and clinics and ambulatory surgery centres, among others.

The major players in the industry are Medtronic plc, Abbott Laboratories, Boston Scientific Corporation, LivaNova PLC, Shree Pacetronix Ltd., and Medico S.p.A., among others.

Purchase Full Report

Mini Report

$ 3499     $2999
  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

$ 5999     $5499
  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update
most popular

Five User License

$ 8299     $7499
  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

$ 10499     $9499
  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Any Question? Speak With An Analyst

Contact Analyst

View A Sample

Request Sample

Did You Miss Anything, Ask Now

Request Customisation
Why Expert Market Research?

Right People

We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.

Right Methodology

We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.

Right Price

We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.

Right Support

Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.

NEWSLETTER